Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2004
10/27/2004EP1470154A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof
10/27/2004EP1470150A2 Corticosteroids nitrate derivatives
10/27/2004EP1470148A2 Double-stranded oligonucleotides
10/27/2004EP1470142A2 Sialic carbohydrates
10/27/2004EP1470137A1 Edg receptor agonists
10/27/2004EP1470126A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor
10/27/2004EP1470124A1 2-(PYRIDIN-2-YLAMINO)-PYRIDO 2,3-d]PYRIMIDIN-7-ONES
10/27/2004EP1470112A1 Substituted pyridazinones as inhibitors of p38
10/27/2004EP1470107A2 Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists
10/27/2004EP1469888A2 Stem cell screening and transplantation therapy for hiv infection
10/27/2004EP1469883A2 Compositions and methods for regulating lymphocyte activation
10/27/2004EP1469882A2 Treatment of ms with goat serum
10/27/2004EP1469856A2 8-heteroaryl xanthine adenosine a sb 2b /sb receptor antagonists
10/27/2004EP1469849A1 Treating stress response with chemokine receptor ccr5 modulators
10/27/2004EP1469846A2 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin
10/27/2004EP1469842A2 Bicyclic cb2 cannabinoid receptor ligands
10/27/2004EP1469733A2 Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells
10/27/2004EP1387701B1 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy
10/27/2004EP1373263B1 Heterocyclic compounds for aging-related and diabetic vascular complications
10/27/2004EP1246791B1 Aminomethyl-phenyl-cyclohexanone derivatives
10/27/2004EP1237578A4 Micro-cluster liquids and methods of making and using them
10/27/2004EP1079860B1 Nicotine immunogen
10/27/2004EP0960108B1 Matrix metalloproteinase inhibitors
10/27/2004EP0914091B9 Ethene containing solutions and use thereof in methods of therapy or prophylaxis
10/27/2004EP0897427B1 Polysaccharide precipitation process
10/27/2004CN1541335A EPF receptor assays, compounds and therapeutic compsns.
10/27/2004CN1541278A Novel molecular target for neurotoxicity
10/27/2004CN1541266A FCE fusion proteins for treatment of allergy and asthma
10/27/2004CN1541224A Antagonistic anti-hTNFSF13b Human antibodies
10/27/2004CN1541217A Chemical compounds
10/27/2004CN1541216A 8-methoxy-(1,2,4) triazolo (1,5-A) pyridine derivatives and their use as adenosine receptor ligands
10/27/2004CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same
10/27/2004CN1541208A 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
10/27/2004CN1541126A Microprojection array having beneficial agent contg coating
10/27/2004CN1541107A Growth factor complex
10/27/2004CN1541097A 2-amino-4, 5-trisubstituted thiazolyl derivatives
10/27/2004CN1541095A 抑制炎症的化合物 The compounds inhibit inflammation
10/27/2004CN1539970A Heterophil neutral leucocyte factor alpha
10/27/2004CN1539837A Analog of nerve growth factor (2S, 4S)-2-(2'substituent)-4-(indole-3-methine)
10/27/2004CN1539816A IL-8 receptor antagonist
10/27/2004CN1539501A Tablet for keeping in mouth prepared from recombined human interferon alpha 2b and producing method
10/27/2004CN1539480A Technique for preparing herbal medicine of seseli mairei Wolff and its usage
10/27/2004CN1539462A Health product of compound propolis and preparing method
10/27/2004CN1539449A Magnetism and drug combined type fragrnant baldric for avoiding plague
10/27/2004CN1539441A Compounded medicine for anti pathogeny and immunoenhancement
10/27/2004CN1539440A Immunopotentiating drugs
10/27/2004CN1172952C Mannosan peptide and its prepn and use
10/27/2004CN1172930C PDE IV inhibiting pyridine derivatives
10/27/2004CN1172929C Substituted indoles for modulating NFKB activity
10/27/2004CN1172718C Dendritic cell stimulatory factor
10/27/2004CN1172715C Medicine for antiimmune disorder and its production technology
10/27/2004CN1172666C Compositions cotaining benzamide disulfide derivative for treating allergic diseases
10/26/2004US6809203 Oxazolo, thiazolo and selenazolo [4,5-C]-quinolin-4-amines and analogs thereof
10/26/2004US6809199 (Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
10/26/2004US6809189 Apoptin-associating protein
10/26/2004US6809113 For therapy of arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease, crohn's disease, multiple sclerosis, nephritis, pancreatitis, pulmonary fibrosis, psoriasis, restenosis transplant rejection
10/26/2004US6809100 Hydroxamic acid derivatives
10/26/2004US6809092 1,3,4,5-tetrahydro-2h-2-benzazepin-2-yl derivatives; cysteine protease inhibitors
10/26/2004US6809090 Nitrogen monoxide synthase and/or lipidic peroxidation inhibitors
10/26/2004US6809077 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration
10/26/2004US6808936 Methods and compositions for use in the diagnosis and treatment of chronic immune disease
10/26/2004US6808877 Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection
10/26/2004US6808710 Contacting cell expressing pd-1 with binding agent; genetic transduction of negative signal
10/26/2004US6808705 For suppressing the proliferation of cancer cells
10/26/2004CA2418634C Pharmaceutical compositions of tizoxanide and nitazoxanide
10/26/2004CA2023811C Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity
10/26/2004CA1341461C T helper cell growth factor
10/21/2004WO2004090541A1 METHOD OF SCREENING DRUG WITH THE USE OF 67 kDa LAMININ RECEPTOR AND DRUG OBTAINED THEREBY
10/21/2004WO2004089913A1 Aminopyrimidine derivatives and their medical use
10/21/2004WO2004089819A1 Functionalized carbon nanotubes, a process for preparing the same and their use in medicinal chemistry
10/21/2004WO2004089818A1 Functionalized carbon nanotubes, a process for preparing the same and their use in medicinal chemistry
10/21/2004WO2004089413A1 Nucleotide and cellular vaccine composition
10/21/2004WO2004089407A2 Zwitterionic immunomodulators for the treatment of asthma and allergy
10/21/2004WO2004089405A1 Therapeutic composition for autoimmune conditions
10/21/2004WO2004089368A1 Therapeutic or preventive agent for dermatitis
10/21/2004WO2004089341A1 Organic compounds
10/21/2004WO2004089282A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/21/2004WO2004067026A8 Regulation of allergen induced gene
10/21/2004WO2004064860A8 Use of tff2, or agents inducing tff2, in the therapy of allergies
10/21/2004WO2004052888B1 Tropane esters and methods for producing and using them
10/21/2004WO2004009556A9 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
10/21/2004WO2003097163A3 Using a selective inos inhibitor for the treatment of respiratory diseases and conditions
10/21/2004WO2003062241A8 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
10/21/2004WO2003045228A3 Methods for treating autoimmune disorders, and reagents related thereto
10/21/2004WO2003026490A3 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules
10/21/2004WO2003000014A3 Spherical protein particles and methods of making and using them
10/21/2004US20040210052 Efficient synthesis of 5-heteroatom-containing-pyrazoles
10/21/2004US20040209948 especially naphthalene sulfonamides, used for treating asthma
10/21/2004US20040209938 Novel 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them
10/21/2004US20040209935 Pyrazole-derived kinase inhibitors and uses thereof
10/21/2004US20040209914 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
10/21/2004US20040209911 Mixture containing rapamycin; absorption efficiency
10/21/2004US20040209908 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments
10/21/2004US20040209901 substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, e.g., 8-(2,6-Difluoro-phenyl)-4-(4-fluoro-2-methyl-phenyl)-2-(2-hydroxy-1-hydroxymethyl-ethylamino)-8H-pyrido[2,3-d]pyrimidin-7-one; CSBP/p38 kinase inhibitors.
10/21/2004US20040209894 e.g., 1-(4-chloroanilino)-4-[2-(pyridin-3-yl)-ethyl]-isoquinoline and 5-[4-(tert-butyl)-anilino]-8-[(6-methoxy-pyridin-3-yl)-methyl]-[1,6]naphthyridine
10/21/2004US20040209879 Piperidinyl derivates as modulators of chemokine receptor activity
10/21/2004US20040209874 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
10/21/2004US20040209870 contain 5-HT ligands used to treat central nervous system disorders
10/21/2004US20040209868 Substituted indoles
10/21/2004US20040209866 1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders
1 ... 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 ... 1172